Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
1988 • 2,463 citations
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
1993 • 1,579 citations
Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum
1993 • 1,119 citations
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
1993 • 1,064 citations
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.
1992 • 880 citations
Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus
1992 • 858 citations
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
1987 • 830 citations
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
1987 • 814 citations
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects
1995 • 705 citations
Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing.
1986 • 686 citations
Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut
1987 • 566 citations
The pharmacological basis of therapeutics
1977 • 434 citations
Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells.
1992 • 323 citations
Biological Effects and Metabolic Rates of Glucagonlike Peptide-1 7–36 Amide and Glucagonlike Peptide-1 7–37 in Healthy Subjects Are Indistinguishable
1993 • 311 citations
Glucagon-like peptide-1, a new hormone of the entero-insular axis
1992 • 290 citations
Insulinotropic Action of Glucagonlike Peptide-I-(7–37) in Diabetic and Nondiabetic Subjects
1992 • 282 citations
Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
1998 • 279 citations
Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM
1997 • 272 citations
Glucagonlike Peptide I (7–37) Actions on Endocrine Pancreas
1989 • 254 citations
Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
1996 • 248 citations
The Pharmacological Basis of Therapeutics.
1966 • 204 citations
Identification and Localization of Glucagon-Like Peptide-1 and Its Receptor in Rat Brain*
1987 • 166 citations
Receptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cells
1988 • 153 citations
Investigation of Glucose-dependent Insulinotropic Polypeptide(1-42) and Glucagon-like Peptide-1-(7-36) Degradation by Dipeptidyl Peptidase IV Using Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry
1996 • 153 citations
Subcutaneous Injection of the Incretin Hormone Glucagon-Like Peptide 1 Abolishes Postprandial Glycemia in NIDDM
1994 • 138 citations
Involvement of Plasma Membrane Dipeptidyl Peptidase IV in Fibronectin-Mediated Adhesion of Cells on Collagen
1985 • 124 citations
Glucagon-Like Peptide-I and the Control of Insulin Secretion in the Normal State and in NIDDM
1993 • 114 citations
Peptidasen II. Zur Lokalisation der Dipeptidylpeptidase IV (DPP IV). Histochemische und biochemische Untersuchung
1979 • 99 citations
Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet
1996 • 95 citations
Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans
1997 • 89 citations
Glucagon‐like peptide‐1 (GLP‐1): a trial of treatment in non‐insulin‐dependent diabetes mellitus
1997 • 86 citations
Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells
1992 • 81 citations
Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
1996 • 75 citations
The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients
1996 • 64 citations
Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP- 1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate
1996 • 45 citations
[Dipeptidyl peptidase activities in various organs of the Wistar rat].
1983 • 4 citations
Cited By (0)
No citing papers found in database